ImmunologyImmunoTargets and TherapyPeer-reviewed
Complement-Activating Multimeric Immunotherapeutic Complexes for HER2-breast cancer immunotherapy
Carole Seguin‐Devaux, Bianca Brandus, Jean‐Marc Plesséria…·Xavier Dervillez
This study develops and tests CoMiX immunotherapeutics that activate complement to kill HER2-positive breast cancer cells, showing significant tumor growth inhibition in xenograft models.
4 citations